Jadi Imaging Holdings Berhad (KLSE:JADI)

Sage Therapeutics Income Statement

Financials in millions MYR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	19.38	26.41	29.07	43.06	45.09
Revenue Growth (YoY)	-26.62%	-9.15%	-32.49%	-4.51%	-4.59%
Cost of Revenue	28.03	30.81	27.55	42.1	38.3
Gross Profit	-8.65	-4.41	1.51	0.96	6.79
Selling, General & Admin	7.62	7.92	7.12	7.94	8.01
Other Operating Expenses	44.16	22.34	2.37	-0.6	-1.06
Operating Expenses	51.78	30.26	9.49	7.33	6.98
Operating Income	-60.43	-34.67	-7.98	-6.38	-0.19
Interest Expense	-0.05	-0.72	-1.18	-1.64	-1.75
Interest & Investment Income	-	0.09	0.14	0.12	0.23
Other Non Operating Income (Expenses)	36.3	-	-	-	-
EBT Excluding Unusual Items	-24.18	-35.3	-9.03	-7.89	-1.71
Pretax Income	-24.18	-35.3	-9.03	-7.89	-1.71
Income Tax Expense	-0.06	-0.03	-0.09	-0.02	0.14
Earnings From Continuing Operations	-24.13	-35.27	-8.93	-7.87	-1.85
Earnings From Discontinued Operations	-	-0.26	-2.1	-	-
Net Income	-24.13	-35.53	-11.03	-7.87	-1.85
Net Income to Common	-24.13	-35.53	-11.03	-7.87	-1.85
Shares Outstanding (Basic)	1,399	1,286	1,076	1,060	1,052
Shares Outstanding (Diluted)	1,399	1,286	1,076	1,060	1,052
Shares Change (YoY)	8.80%	19.48%	1.52%	0.79%	1.55%
EPS (Basic)	-0.02	-0.03	-0.01	-0.01	-0.00
EPS (Diluted)	-0.02	-0.03	-0.01	-0.01	-0.00
Free Cash Flow	-16.14	-3.78	5.17	1.12	-8.73
Free Cash Flow Per Share	-0.01	-0.00	0.01	0.00	-0.01
Gross Margin	-44.65%	-16.69%	5.21%	2.23%	15.05%
Operating Margin	-311.85%	-131.28%	-27.45%	-14.80%	-0.42%
Profit Margin	-124.51%	-134.54%	-37.94%	-18.29%	-4.10%
Free Cash Flow Margin	-83.27%	-14.30%	17.80%	2.60%	-19.36%
EBITDA	-58.64	-30.97	-2.99	-1.41	3.43
EBITDA Margin	-	-117.27%	-10.28%	-3.27%	7.60%
D&A For EBITDA	1.79	3.7	4.99	4.97	3.62
EBIT	-60.43	-34.67	-7.98	-6.38	-0.19
EBIT Margin	-	-131.28%	-27.45%	-14.80%	-0.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.